Galapagos NV is a Belgium-based biotechnology company. The Company is divided into two operating divisions: Drug Discovery and BioFocus DPI. The Drug Discovery division has programs in bone and joint diseases, including osteoarthritis, osteoporosis and rheumatoid arthritis. The BioFocus DPI service division offers a suite of target-to-drug discovery products and services to pharmaceutical and biotechnology companies, encompassing target discovery and drug discovery services through to delivery of pre-clinical candidates. The Company also forms strategic long-term alliances for the majority of its research programs with large pharmaceutical companies. Galapagos NV's operations are located in Belgium, France, Switzerland, the Netherlands, the United Kingdom and the United States.